J&J's (JNJ) Janssen unit marketed its Risperdal drug to children in 2004 even though the FDA...

|By:, SA News Editor

J&J's (JNJ) Janssen unit marketed its Risperdal drug to children in 2004 even though the FDA didn't approve such use until 2006, a company memo shows. The document was produced yesterday in a case in which Texas is suing J&J for $579M for defrauding the state's Medicaid scheme. The case is one of several J&J has been facing.